Michael Fralick

General Internist

MD, SM, FRCPC, PhD (c)

I completed my undergraduate degree at Queen's University in Life Sciences and my Medical Degree at the University of Toronto. I then completed my Internal Medicine residency at the University of Toronto including a year at St. Michael's Hospital as the Chief Medical Resident. In 2016, I moved to Boston to pursue a Master's of Science at Harvard in Clinical Epidemiology and two Research Fellowships. The first was in Pharmacoepidemiology with the Division of Pharmacoepidemiology and Pharmacoeconomics, and the second was in Health Policy with the Program On Regulation Therapeutics and Law (PORTAL), both at the Brigham and Women's Hospital.

I am currently completing a PhD in Clinical Epidemiology at the Institute for Health Policy, Management, and Evaluation. My thesis focuses on using tree-based machine learning methods to understand the risks and benefits of a new class of medications for diabetes (SGLT2 inhibitors). I am a board-certified general internist in Canada and the United States, and clinically as a General Internist both in Toronto and in Sault Ste. Marie (about 14 hours north of Toronto).